Iris Biotech GmbH

Starting in 2001 with a small range of commodities for peptides, Iris Biotech GmbH developed its portfolio to a unique list of standard reagents and unusual building blocks extended by our custom synthesis service making us the number one address for any (un-)usual compound required for the modification of peptides. Our mission as qualified supplier is to support our customers in their ongoing projects from research scale to commercial production by providing our know-how and latest products together with the required analytics and documentation. In the field of drug discovery, we offer protected amino acids, coupling reagents, linkers und resins,...

Peptide synthesis,pegylation,click chemistry,enzyme substrates for diagnsotics,resins,drug delivery,drug discovery,adc linkers,amino acids,amadori and maillard reaction products,linkerology,and protacs

Iris biotech gmbh operates in the Biotechnology research industry.

Iris biotech gmbh's revenue is 11m - 100m

Iris biotech gmbh has 11 - 50 employees.